Medical Science Liaison - Oncology TN/GA region

United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, PharmaceuticalsIndustries

Requirements

Candidates must possess an advanced healthcare or scientific degree (Ph.D., Pharm.D, M.D., D.N.P.) or a Master's degree, with MSL experience being preferred but not required. The applicant must reside within the Tennessee and Georgia territory. Strong communication, problem-solving, and strategic thinking skills are essential, along with the ability to work independently and collaboratively in a fast-paced environment. Experience in establishing strong working relationships with internal stakeholders and external customers is also necessary.

Responsibilities

The Medical Science Liaison will provide scientific and clinical presentations on Natera's oncology products, acting as a medical and scientific resource for internal teams. They will establish and manage relationships with Key Opinion Leaders, Healthcare Providers, and Customers, and represent Natera at scientific and clinical congress meetings. Responsibilities include collaborating with lab operations, supporting clinical trial initiatives, and engaging in continuous learning to maintain expertise. The role requires extensive travel (over 60%) and ensuring medical accuracy in communication materials.

Skills

Oncology

Scientific Presentations

Clinical Presentations

Key Opinion Leader (KOL) Engagement

Healthcare Provider Engagement

Clinical Trial Support

Research Initiatives

Medical Accuracy

Communication Tools

Publications

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free